| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | 10%+ Owner | Voting Common Stock | 1,278,838 | $6,353,907 | $4.97 | 20 Jul 2021 | Indirect |
| TScan Therapeutics, Inc. | 10%+ Owner | Voting Common Stock | 914,634 | $4,544,359 | $4.97 | 20 Jul 2021 | Direct |
| TScan Therapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | 20 Jul 2021 | Indirect | ||
| TScan Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | 20 Jul 2021 | Indirect | ||
| TScan Therapeutics, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | 20 Jul 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 20 Jul 2021 | 5 | $1,999,995 | 4 | 10%+ Owner | 22 Jul 2021, 16:46 |
| TCRX | TScan Therapeutics, Inc. | 15 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 15 Jul 2021, 18:19 |